Cash & equivalents increased 39.3%
Cash & equivalents changed +39.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +39.3% from the comparable as-filed period.
Gross profit changed +37.2% from the comparable as-filed period.
Net income changed +22.5% from the comparable as-filed period.
Operating income changed +32.6% from the comparable as-filed period.
Revenue changed +27.6% from the comparable as-filed period.
Gross margin changed +179 basis points from the comparable as-filed period.
Inventory changed +16.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed -15.5% from the comparable as-filed period.
Operating margin changed +43 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.